Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Frontiers in Pharmacology
|
December 7, 2013
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
Chris E Adkins, Rajendar K Mittapalli, Vamshi K Manda, et al.
Pharmaceutics
|
January 25, 2025
Single Exposure to Low-Intensity Focused Ultrasound Causes Biphasic Opening of the Blood-Brain Barrier Through Secondary Mechanisms
Tasneem A Arsiwala, Kathryn E Blethen, Cullen P Wolford, et al.
Pharmacological Research
|
April 1, 2018
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases
Neal Shah, Afroz S Mohammad, Pushkar Saralkar, et al.
Neuro-Oncology
|
July 13, 2014
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
Aki Morikawa, David M Peereboom, Helen R Thorsheim, et al.
Molecular Cancer Therapeutics
|
September 5, 2013
Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model
Rajendar K Mittapalli, Xinli Liu, Chris E Adkins, et al.
Pharmaceutical Patent Analyst
|
July 8, 2014
Novel treatment strategies for brain tumors and metastases
Salma E El-Habashy, Alaa M Nazief, Chris E Adkins, et al.
Military Medical Research
|
June 30, 2026
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Gui-Long Tanzhu, Liu Chen, Jiao-Yang Ning, et al.
Fluids and Barriers of the CNS
|
September 8, 2022
Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model
Tasneem A Arsiwala, Samuel A Sprowls, Kathryn E Blethen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer
Paul R Lockman, Rajendar K Mittapalli, Kunal S Taskar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 8, 2008
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity
Linda P Dwoskin, Thomas E Wooters, Sangeetha P Sumithran, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Frontiers in Pharmacology
|
December 7, 2013
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
Chris E Adkins, Rajendar K Mittapalli, Vamshi K Manda, et al.
Pharmaceutics
|
January 25, 2025
Single Exposure to Low-Intensity Focused Ultrasound Causes Biphasic Opening of the Blood-Brain Barrier Through Secondary Mechanisms
Tasneem A Arsiwala, Kathryn E Blethen, Cullen P Wolford, et al.
Pharmacological Research
|
April 1, 2018
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases
Neal Shah, Afroz S Mohammad, Pushkar Saralkar, et al.
Neuro-Oncology
|
July 13, 2014
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
Aki Morikawa, David M Peereboom, Helen R Thorsheim, et al.
Molecular Cancer Therapeutics
|
September 5, 2013
Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model
Rajendar K Mittapalli, Xinli Liu, Chris E Adkins, et al.
Pharmaceutical Patent Analyst
|
July 8, 2014
Novel treatment strategies for brain tumors and metastases
Salma E El-Habashy, Alaa M Nazief, Chris E Adkins, et al.
Military Medical Research
|
June 30, 2026
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Gui-Long Tanzhu, Liu Chen, Jiao-Yang Ning, et al.
Fluids and Barriers of the CNS
|
September 8, 2022
Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model
Tasneem A Arsiwala, Samuel A Sprowls, Kathryn E Blethen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer
Paul R Lockman, Rajendar K Mittapalli, Kunal S Taskar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 8, 2008
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity
Linda P Dwoskin, Thomas E Wooters, Sangeetha P Sumithran, et al.
Page
of 8